Welcome to Marinus Pharmaceuticals

Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of ganaxolone, the most advanced neurosteroid in development. Ganaxolone is being studied for the treatment of serious neurological and psychiatric disorders such as epilepsy, posttraumatic stress disorder and fragile-X syndrome.

Latest News Releases

» Marinus Pharmaceuticals Issued Patent for Ganaxolone
» Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome